Worried that GlaxoSmithKline or AstraZeneca might pull up their U.K. roots in the wake of Brexit? Rest easy. Both companies are set to reassure the world this…

Pharma's gifts to politicians--one, in particular--have been in the spotlight since presidential candidate Hillary Clinton announced her VP pick Friday.

Roche won another reprieve in its fight againstthousands of Accutane safety claims. The drugmaker persuaded a New Jersey appeals court to overturn an $18M jury…

With the vast majority of drugs and drug ingredients being manufactured outside the U.S., the FDA has had to step up its international oversight and often ban…

The sun is finally shining on drug company payments to doctors in Europe, and payment information has begun to trickle out.

Valeant just got a new weapon in its battle with AstraZeneca for the opioid-induced constipation throne. But don't expect oral Relistor to power that…

What’s in a new name? For a Takeda and Lundbeck antidepressant, new marketing work.

Tenet Partners is out with its ninth annual evaluation of the most powerful brands, and a pair of pharmas locked up top spots on the list.

Failings at an Indian CRO have tripped up Novartis and Teva as the European Medicines Agency said today that it would suspend some approved generics from the…